Bavarian Nordic A/S (CPH: BAVA)
266.00
-6.30 (-2.31%)
Aug 30, 2024, 4:59 PM CET
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.43B DKK in the quarter ending June 30, 2024, a decrease of -28.14%. This brings the company's revenue in the last twelve months to 6.08B, up 9.94% year-over-year. In the year 2023, Bavarian Nordic had annual revenue of 7.06B with 124.14% growth.
Revenue (ttm)
6.08B
Revenue Growth
+9.94%
P/S Ratio
3.41
Revenue / Employee
4.40M
Employees
1,379
Market Cap
20.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
Dec 31, 2019 | 662.49M | 161.87M | 32.33% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk A/S | 258.00B |
Coloplast A/S | 26.30B |
Genmab A/S | 19.02B |
Demant A/S | 22.84B |
Zealand Pharma A/S | 367.97M |
H. Lundbeck A/S | 20.67B |
H. Lundbeck A/S | 20.67B |
ALK-Abelló A/S | 5.18B |
Bavarian Nordic News
- 1 day ago - Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox - MarketWatch
- 3 days ago - Bavarian Nordic’s Big Rally Just the Latest in Volatile History - BNN Bloomberg
- 4 days ago - Singapore approves Bavarian's mpox vaccine Jynneos - Reuters
- 4 days ago - Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Singapore - GlobeNewsWire
- 5 days ago - Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain - Benzinga
- 8 days ago - Undercovered Dozen: Delcath Systems, Bavarian Nordic, Tempus AI, Journey Energy + - Seeking Alpha
- 8 days ago - Undercovered Dozen: Delcath Systems, Bavarian Nordic, Tempus AI, Journey Energy + - Seeking Alpha
- 8 days ago - Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - GlobeNewsWire